Literature DB >> 16427717

Place of residence and distance to medical care influence the diagnosis of hepatitis C: a population-based study.

Elisabeth Monnet1, Estelle Collin-Naudet, Solange Bresson-Hadni, Anne Minello, Vincent Di Martino, Didier Carel, Valérie Jooste, Alice Gagnaire, Philippe Evrard, Bénédicte Obert-Clerc, Jean-Philippe Miguet, Patrick Hillon.   

Abstract

BACKGROUND/AIMS: In France, geographic access to medical care may affect the diagnosis of hepatitis C. The aims of this study were to compare the detection rates of hepatitis C in urban and rural areas after adjusting for distance to medical care, and evaluating the impact of the place of residence on patients' clinical characteristics.
METHODS: Between 1994 and 2001, 1938 newly detected cases were recorded in a French population of 1,005,817 inhabitants. Age and sex-adjusted detection rates for 10(5) inhabitants were estimated for urban and rural areas and for classes of distance to the nearest practitioner.
RESULTS: Detection rates were lower in rural than in urban areas [14.1, (95CI: 12.5-15.7) versus 24.7, (95CI: 23.5-26.0)] and decreased as the distance to the general practitioner increased [27.0, (95CI: 25.5-28.4) versus 13.7, (95CI: 12.1-15.3) for a cutoff value of 1.5 km]. In multivariate analyses, detection rates were only influenced by the distance to general practitioner. Hepatocellular carcinoma at diagnosis was more frequent among rural than among urban patients (adjusted OR = 2.28, 95CI: 0.97-5.39, P = 0.059).
CONCLUSIONS: A poorer geographic access to care explained the lower detection of hepatitis C in rural areas. Hepatocellular carcinoma was more frequent in rural patients. It may result from later detection and/or involvement of environmental factors on hepatocarcinogenesis.

Entities:  

Mesh:

Year:  2005        PMID: 16427717     DOI: 10.1016/j.jhep.2005.11.044

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  Accessibility and utilization patterns of a mobile medical clinic among vulnerable populations.

Authors:  Britton A Gibson; Debarchana Ghosh; Jamie P Morano; Frederick L Altice
Journal:  Health Place       Date:  2014-05-21       Impact factor: 4.078

2.  Rates of surveillance and management of hepatocellular carcinoma in patients evaluated at a liver transplant center.

Authors:  Janice H Jou; Po-Hung Chen; Alison Jazwinski; Iliana Bouneva; Alastair D Smith; Andrew J Muir
Journal:  Dig Dis Sci       Date:  2010-08-04       Impact factor: 3.199

3.  Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum.

Authors:  Warren H Tseng; Thomas R Stevenson; Robert J Canter; Steven L Chen; Vijay P Khatri; Richard J Bold; Steve R Martinez
Journal:  Plast Reconstr Surg       Date:  2010-12       Impact factor: 4.730

4.  Viral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients.

Authors:  W Jay Christian; Claudia Hopenhayn; Amy Christian; Deana McIntosh; Alvaro Koch
Journal:  Public Health Rep       Date:  2010 Jan-Feb       Impact factor: 2.792

5.  Capacity enhancement of hepatitis C virus treatment through integrated, community-based care.

Authors:  Warren D Hill; Gail Butt; Maria Alvarez; Mel Krajden
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

Review 6.  Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors.

Authors:  Magdalena Harris; Tim Rhodes
Journal:  Harm Reduct J       Date:  2013-05-07

7.  Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma.

Authors:  Shimul A Shah; Alice C Wei; Sean P Cleary; Ilun Yang; Ian D McGilvray; Steven Gallinger; David R Grant; Paul D Greig
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.267

8.  No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity.

Authors:  Takuya Hirosawa; Naoki Morimoto; Kouichi Miura; Toshiyuki Tahara; Toshimitsu Murohisa; Yukishige Okamura; Takashi Sato; Norikatsu Numao; Masato Imai; Shigeo Tano; Kozue Murayama; Hidekazu Kurata; Iwao Ozawa; Yukimura Fukaya; Hiroaki Yoshizumi; Shunji Watanabe; Mamiko Tsukui; Yoshinari Takaoka; Hiroaki Nomoto; Norio Isoda; Hironori Yamamoto
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.